Quality, purity, and safety of Immunoglobulin anti-rhesus Rh (D) human correspond with the European Pharmacopoeia regulations for the finished product and raw materials 2 validated stages of virus inactivation, including SD treatmentDonors were examined for the absence of antigen and antibodies to HIV 1,2, HCV; plasma pools were tested by IFA for the absence of HBsAg, antigen, and antibodies to HIV 1,2, antibodies to HBV and PCR method for the HCV, HBV NA. Parvovirus B-19 and HIV 1,2 Ready to use Indications: For prophylaxis in the pre- and post-natal period in Rh-negative women unresponsive to the Rho (D) antigen; with artificial termination of pregnancy in Rh-negative women, unresponsive to the Rho antigen, in the case of Rh-positive blood belonging to the husband; with miscarriage or the threat of miscarriage; when performing amniocentesis; with injuries of the abdominal cavity during pregnancy.
UA
